- Featured Product
- KD/KO Validated
Galectin-9 Polyklonaler Antikörper
Galectin-9 Polyklonal Antikörper für IF, IP, WB, ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus
Anwendung
WB, IP, IHC, IF, ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 17938-1-AP
Synonyme
Galerie der Validierungsdaten
Geprüfte Anwendungen
Erfolgreiche Detektion in WB | U-937-Zellen, HeLa-Zellen, HepG2-Zellen, HL-60-Zellen, NIH/3T3-Zellen, SGC-7901-Zellen |
Erfolgreiche IP | U-937-Zellen |
Erfolgreiche Detektion in IF | HeLa-Zellen |
Empfohlene Verdünnung
Anwendung | Verdünnung |
---|---|
Western Blot (WB) | WB : 1:500-1:1000 |
Immunpräzipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunfluoreszenz (IF) | IF : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Veröffentlichte Anwendungen
KD/KO | See 1 publications below |
WB | See 9 publications below |
IHC | See 4 publications below |
IP | See 1 publications below |
Produktinformation
17938-1-AP bindet in WB, IP, IHC, IF, ELISA Galectin-9 und zeigt Reaktivität mit human, Maus
Getestete Reaktivität | human, Maus |
In Publikationen genannte Reaktivität | human |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Polyklonal |
Typ | Antikörper |
Immunogen | Galectin-9 fusion protein Ag12209 |
Vollständiger Name | lectin, galactoside-binding, soluble, 9 |
Berechnetes Molekulargewicht | 323 aa, 36 kDa |
Beobachtetes Molekulargewicht | 45 kDa |
GenBank-Zugangsnummer | BC110340 |
Gene symbol | LGALS9 |
Gene ID (NCBI) | 3965 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Antigen-Affinitätsreinigung |
Lagerungspuffer | PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3. |
Lagerungsbedingungen | Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
The galectins, formerly known as S-type lectins, are a family of β-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. Galectin-9 (LGALS9) is a tandem repeat-type member of the galectin family. It has three isoforms (named galectin-9L, galectin-9M, and galectin-9S): long type of 355 amino acids, medium type of 323 amino acids, and short type of 311 amino acids. Galectin-9 is ubiquitously expressed in a variety of tissues, including lymph nodes and spleen, and overexpressed in Hodgkin disease tissue. It is involved in chemoattraction, apoptosis, and the regulation of cell differentiation and has anti-allergic effects. It has been reported that galectin-9 is a ligand for Tim-3, through which galectin-9 can induce T-helper type 1 lymphocyte (Th1) death.
Protokolle
Produktspezifische Protokolle | |
---|---|
WB protocol for Galectin-9 antibody 17938-1-AP | Protokoll herunterladen |
IF protocol for Galectin-9 antibody 17938-1-AP | Protokoll herunterladen |
IP protocol for Galectin-9 antibody 17938-1-AP | Protokoll herunterladen |
Standard-Protokolle | |
---|---|
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |
Publikationen
Species | Application | Title |
---|---|---|
Front Mol Neurosci Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease | ||
J Nutr Biochem Isothiocyanates attenuate immune checkpoint blockage therapy in gastric cancer via induction of PD-L1 expression | ||
Front Immunol Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion. | ||
Stem Cell Res Ther Mesenchymal stem cells alleviate experimental autoimmune cholangitis through immunosuppression and cytoprotective function mediated by galectin-9. | ||
Immunotherapy Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancer |